Kaiser Permanente Vallejo Medical Center

Publications

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation

Jennifer K. Litton , Hope S. Rugo , Johannes Ettl +15 more

Among patients with advanced breast cancer and a germline BRCA1/2 mutation, single-agent talazoparib provided a significant benefit over standard chemotherapy with respect to pr...

2018 New England Journal of Medicine 1983 citations

Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer

Andrew Tutt , Judy E. Garber , Bella Kaufman +36 more

Among patients with high-risk, HER2-negative early breast cancer and germline BRCA1 or BRCA2 pathogenic or likely pathogenic variants, adjuvant olaparib after comp...

2021 New England Journal of Medicine 1483 citations